Epcoritamab  - relapsed or refractory large diffuse B cells lymphoma after two or more lines of systemic therapy

Bull Cancer. 2024 Apr 16:S0007-4551(24)00117-6. doi: 10.1016/j.bulcan.2024.02.011. Online ahead of print.NO ABSTRACTPMID:38631985 | DOI:10.1016/j.bulcan.2024.02.011

Source: Bulletin du Cancer - April 17, 2024 Category: Cancer & Oncology Authors: Hedi Bensaber Victoria Cacheux Source Type: research